As we look ahead to 2025, Barclays is feeling positive about the stock market. Despite a few bumps on the horizon, they believe global shares are still a better bet than bonds or cash. If you’re looking to grow your money in the year ahead, Barclays has picked out three stocks they think are worth buying — all with big potential for growth according to CNBC.
Barclays’ picks for 2025 are a mix of energy, pharma, and tech stocks — each with solid potential for growth. Whether you’re into big names like Shell, looking for pharma breakthroughs with AstraZeneca, or eyeing the booming tech sector with Besi, these stocks could help your portfolio grow next year or start it if you are looking to get into investing. If you’re thinking about where to invest, these three could be worth a closer look.
Shell. Instead of forking out money for oil and gas, there’s a chance to make a big win in the energy sector with Shell, the oil and gas giant. Barclays is confident in the stock, with a target price of £36 ($45.60), meaning they think it could rise by around 40%. The reason? Shell is doing well on the operational side, making plenty of cash, and rewarding shareholders with dividends and buybacks.
Experts at Barclays say Shell is undervalued at the moment and is offering solid growth potential for 2025. They expect Shell to generate around $23 billion in free cash flow, which gives the company plenty of room to pay out dividends to investors and buy back shares. If you’re looking for a safe bet with some decent growth potential, Shell could be a good pick.
